5:33 PM
Dec 30, 2015
 |  BC Extra  |  Clinical News

Tetra candidate backed by NIH's Blueprint enters clinic

Tetra Discovery Partners LLC (Grand Rapids, Mich.) began Phase I testing of BPN14770, the first candidate funded by NIH's Blueprint Neurotherapeutics Network (BPN) to reach the clinic. The...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >